These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10785251)

  • 1. Regional differences of cerebrovascular reactivity effected by calcium channel blocker - dotarizine.
    Kuridze N; Czernicki Z; Jarus-Dziedzic K; Jurkiewicz J; Cervos-Navarro J
    J Neurol Sci; 2000 Apr; 175(1):13-6. PubMed ID: 10785251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasostabilizing effect of Dotarizine (Ca(2+)-channel blocker) on cerebrovascular reactivity in rabbits.
    Kuridze N; Czernicki Z; Jarus-Dziedzic K; Jurkiewicz J; Cervos-Navarro J
    Neurol Res; 2000 Mar; 22(2):229-32. PubMed ID: 10763515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral administration of dotarizine on cerebrovasculature subjected to constriction followed by dilatation in rabbits.
    Jarus-Dziedzic K; Czernicki Z; Cervos-Navarro J; Jurkiewicz J
    Acta Neurochir (Wien); 1999; 141(11):1209-12. PubMed ID: 10592122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Dotarizine (Ca2+ channel blocker) on cerebral vessel reactivity in animals subjected to hyperventilation and anoxia.
    Czernicki Z; Kuridze N; Jurkiewicz J; Cervós-Navarro J
    Acta Neurochir Suppl; 1997; 70():209-11. PubMed ID: 9416324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Dotarizine--(Ca2+ channel blocker)--on vascular reactivity and ultrastructure of cerebral capillaries in animals subjected to anoxia.
    Kuridze N; Gajkowska B; Czernicki Z; Jurkiewicz J; Cervos-Navarro J
    Folia Neuropathol; 1998; 36(2):101-8. PubMed ID: 9757621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the calcium channel blockers Dotarizine and Flunarizine on cerebrovascular reactivity.
    Czernicki Z; Jurkiewicz J; Bojanowski K; Piechnik S; Cervos-Navarro J
    J Neurol Sci; 1996 Nov; 143(1-2):60-3. PubMed ID: 8981299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dotarizine on CO2-dependent cerebrovascular reactivity.
    Chomicki J; Jurkiewicz J; Zabolotny W; Czernicki Z; Cervos-Navarro J
    Acta Neurochir (Wien); 1995; 136(3-4):186-8. PubMed ID: 8748852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility.
    Ruiz-Nuño A; Villarroya M; Cano-Abad M; Rosado A; Balfagón G; López MG; García AG
    Eur J Pharmacol; 2001 Jan; 411(3):289-99. PubMed ID: 11164387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dotarizine on 45Ca2+ movements and contractile responses in vascular smooth muscle.
    Tejerina T; Chulia T; Gonzalez P
    Eur J Pharmacol; 1993 Aug; 239(1-3):75-81. PubMed ID: 8223916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.
    Montiel C; Herrero CJ; García-Palomero E; Renart J; García AG; Lomax RB
    Eur J Pharmacol; 1997 Aug; 332(2):183-93. PubMed ID: 9286620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular effects of dotarizine, a piperazine derivative, in the goat. An in vivo and in vitro complementary study.
    Torregrosa G; Barberá MD; Ortí M; Centeno JM; Salom JB; Alborch E
    Arzneimittelforschung; 1999 Aug; 49(8):668-72. PubMed ID: 10483512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+.
    Novalbos J; Abad-Santos F; Zapater P; Cano-Abad MF; Moradiellos J; Sánchez-García P; García AG
    Eur J Pharmacol; 1999 Feb; 366(2-3):309-17. PubMed ID: 10082213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dotarizine versus flunarizine as calcium antagonists in chromaffin cells.
    Villarroya M; Gandía L; Lara B; Albillos A; López MG; García AG
    Br J Pharmacol; 1995 Jan; 114(2):369-76. PubMed ID: 7881736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of GB34 acupuncture on hyperventilation-induced carbon dioxide reactivity and cerebral blood flow velocity in the anterior and middle cerebral arteries of normal subjects.
    Moon SK; Kwon S; Cho SY; Park SU; Jung WS; Park JM; Ko CN; Cho KH; Son JH
    Acupunct Med; 2019 Oct; 37(5):277-282. PubMed ID: 31412706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood flow changes in patients with probable medication-overuse headache.
    Savrun FK; Goksan B; Savrun M; Sahin R; Sahin S
    Funct Neurol; 2008; 23(2):83-6. PubMed ID: 18671908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intrathecal dotarizine and nimodipine treatments in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits.
    Onal MB; Solmaz I; Civelek E; Kircelli A; Tehli O; Izci Y; Erdogan E; Gonul E
    Acta Neurochir Suppl; 2011; 110(Pt 2):55-60. PubMed ID: 21125446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients.
    Lassen LH; Jacobsen VB; Haderslev PA; Sperling B; Iversen HK; Olesen J; Tfelt-Hansen P
    J Headache Pain; 2008 Jun; 9(3):151-7. PubMed ID: 18437288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in the cerebrovascular reserve following acute global ischemia in rabbits.
    Sapieja W; Kuridze N; Czernicki Z
    Acta Neurochir Suppl; 1997; 70():59-61. PubMed ID: 9416278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimigraine dotarizine blocks P/Q Ca2+ channels and exocytosis in a voltage-dependent manner in chromaffin cells.
    Ruiz-Nuño A; Mayorgas I; Hernández-Guijo JM; Olivares R; García AG; Gandía L
    Eur J Pharmacol; 2003 Nov; 481(1):41-50. PubMed ID: 14637173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dotarizine on peripheral and pulmonary circulation and cardiac dynamics in dogs.
    Cartheuser CF; Brasó A; Sacristán A; Ortiz JA
    Pharmacology; 1994 Mar; 48(3):187-93. PubMed ID: 8153146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.